Skip to main content
PAHC
NASDAQ Life Sciences

Phibro Q1 Sales Rise 6% to $386.8M, FY2027 Guidance Held

Tom Rudovsky · Reported by BusinessWire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$39.32
Mkt Cap
$1.601B
52W Low
$28.25
52W High
$60.08
52W Position info
39% above low
Off High info
35% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

PAHC sits 39% above its 52-week low of $28.25.

Summary

Phibro opened fiscal 2027 with net sales of $386.8 million, up 6% year over year, and adjusted diluted EPS of $0.79 versus $0.73 a year ago. Net income rose 11% to $29.5 million. Management said the quarter beat its own plan, led by Mineral Nutrition (sales up 17% on higher zinc oxide, copper and trace mineral prices) and Performance Products (up 16%), while core Animal Health grew 3% with adjusted EBITDA slightly below last year at $73.9 million. The company kept FY2027 guidance unchanged at $1.55-$1.60 billion in net sales and $258-$268 million in adjusted EBITDA, and the outlook still assumes no additional virginiamycin sales in Brazil — CEO Dani Bendheim flagged that a Brazilian regulatory approval for therapeutic claims would be pure upside. Gross leverage sits at 2.9x with $739.6 million of total debt. The earnings call is November 5 at 9:00 AM ET.

At the time of this announcement, PAHC was trading at $39.32 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $28.25 to $60.08. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

PAHC - Latest Insights

PAHC
Aug 26, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $35.93
Real-time Price: $33.34 info
Change: -$2.59 (-7%) info
Market Cap: $1.354B info
PAHC
Aug 26, 2026, 4:20 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $35.93
Real-time Price: $33.34 info
Change: -$2.59 (-7%) info
Market Cap: $1.354B info
PAHC
Aug 26, 2026, 4:14 PM EDT
Filing Type: 10-K
Importance Score:
7
Price at Filing: $35.93
Real-time Price: $33.34 info
Change: -$2.59 (-7%) info
Market Cap: $1.354B info
PAHC
Jun 26, 2026, 5:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $31.69
Real-time Price: $33.34 info
Change: +$1.65 (+5%) info
Market Cap: $1.354B info
PAHC
May 22, 2026, 4:24 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $33.26
Real-time Price: $33.34 info
Change: +$0.080 (+0.24%) info
Market Cap: $1.354B info